Latest News and Press Releases

Borregaard has experienced an unforeseen outage at a facility at the Sarpsborg site, which supplies a key chemical used in the production of speciality cellulose. During the period of the outage,...

Borregaard's Board of Directors has issued 30,000 share options in relation to the CEO appointment. Reference is made to stock exchange release on 23 May 2025. The options will expire after five...

Tom Erik Foss-Jacobsen assumed his position as Borregaard’s new CEO on 1 August (see notice to Oslo Stock Exchange 23 May 2025). “Borregaard is well positioned with six production units, three...

Borregaard’s operating revenues increased to NOK 2,045 million (NOK 1,949 million)2 in the 2nd quarter of 2025. EBITDA1 reached NOK 522 million (NOK 510 million). The result in BioSolutions and...

9 July 2025: Borregaard ASA (”Borregaard”, OSE ticker: BRG) Presentation of Q2 2025 results Borregaard will report second quarter 2025 results on Wednesday 16 July 2025 at 07:00 CEST. A stock...

Borregaard ASA has issued a commercial paper ISIN NO0013597476 of NOK 100,000,000. Start date: 19 June, 2025Maturity: 19 September, 2025Coupon: 4.78 %Organised by: DNB CarnegieSarpsborg, 17 June 2025...

Knut-Harald Bakke has been appointed EVP BioSolutions, effective 1 August 2025. He will also join the Group Executive Management on the same date. Bakke succeeds Tom Erik Foss-Jacobsen, who will...

John Arne Ulvan, member of the board of Borregaard ASA, has on 27 May 2025 purchased 2,000 shares in Borregaard ASA at a price of NOK 188.04 per share. Following this transaction, John Arne Ulvan owns...

Tove Andersen, member of the board of Borregaard ASA, has on 27 May 2025 purchased 2,000 shares in Borregaard ASA at a price of NOK 187.92 per share. Following this transaction, Tove Andersen owns...

Tom Erik Foss-Jacobsen has been appointed CEO of Borregaard ASA. He succeeds Per A. Sørlie, who will retire after 26 years in the position (see notice to Oslo Stock Exchange 3 December 2020). The...